Moneycontrol
you are here: HomeNewsIndia
Last Updated : Sep 15, 2017 08:03 PM IST | Source: PTI

Laurus Labs receives US FDA inspection report

Laurus Labs Ltd on Friday said it has received the establishment inspection report from the US Food and Drug Administration for its finished dosage formulations and active pharmaceutical ingredients manufacturing plant.

Q22. This team of scientists, from the Institute of Genomics and Integrative Biology under the Council of Scientific and Industrial Research, studied rupee notes using—possibly for the first time—a shotgun metagenome sequencing approach. This method employs a relatively new analytics and sequencing approach with complex data to identify certain thing in the note? What is it?
Q22. This team of scientists, from the Institute of Genomics and Integrative Biology under the Council of Scientific and Industrial Research, studied rupee notes using—possibly for the first time—a shotgun metagenome sequencing approach. This method employs a relatively new analytics and sequencing approach with complex data to identify certain thing in the note? What is it?

Laurus Labs Ltd on Friday said it has received the establishment inspection report from the US Food and Drug Administration for its finished dosage formulations and active pharmaceutical ingredients manufacturing plant located in Achutapuram of Vishakhapatnam.

In a regulatory filing the city-based drug maker said FDA inspected the unit in May.

The company further said the same unit had also completed the BGV Hamburg (German Regulatory Authority) inspection while the WHO successfully inspected the units 1 and 3 located at Parawada, Visakhapatnam during this month.

Laurus Labs' shares closed at Rs 549.80 almost flat on the Bombay Stock Exchange.
First Published on Sep 15, 2017 08:02 pm

tags #India

Sections
Follow us on
Available On